Matt Britz
Vorstandsvorsitzender bei Affyimmune Therapeutics, Inc.
Profil
Matt Britz is currently the Chief Executive Officer at Affyimmune Therapeutics, Inc. He started this position in 2021 and it is ongoing.
Prior to his current role, he obtained a graduate degree from Washington University in St. Louis and an undergraduate degree from the University of Massachusetts.
Aktive Positionen von Matt Britz
Unternehmen | Position | Beginn |
---|---|---|
Affyimmune Therapeutics, Inc.
Affyimmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Affyimmune Therapeutics, Inc. engages in the development of engineered immune cells to fight cancer disease. The company was founded by Gang Song on August 16, 2016 and is headquartered in Natick, MA. | Vorstandsvorsitzender | 19.03.2024 |
Ausbildung von Matt Britz
University of Massachusetts | Undergraduate Degree |
Washington University in St. Louis | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Affyimmune Therapeutics, Inc.
Affyimmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Affyimmune Therapeutics, Inc. engages in the development of engineered immune cells to fight cancer disease. The company was founded by Gang Song on August 16, 2016 and is headquartered in Natick, MA. | Commercial Services |